Heron Therapeutics, Inc. (HRTX) Ownership

$1.40

$0.09 (6.87%)
Last update: 04:00 PM EST
Day's range
$1.32
Day's range
$1.47

Heron Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RUBRIC CAPITAL MANAGEMENT LP 05/14/2025 26.71 M $58.77 M   0.00% 17.40%
BLACKROCK, INC. 05/02/2025 8.56 M $18.84 M   -0.32% 5.58%
VANGUARD GROUP INC 05/09/2025 8.23 M $18.10 M   0.83% 5.36%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 7.85 M $17.27 M   -7.62% 5.12%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 05/15/2025 6.99 M $15.37 M   0.00% 4.55%
PALISADE CAPITAL MANAGEMENT, LP 04/29/2025 5.29 M $11.63 M   34.65% 3.44%
POINT72 ASSET MANAGEMENT, L.P. 07/21/2025 4.78 M $10.51 M   55.27% 3.11%
TEJARA CAPITAL LTD 05/13/2025 4.58 M $10.07 M   -1.81% 2.98%
STATE STREET CORP 05/15/2025 3.25 M $7.16 M   3.42% 2.12%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 3.11 M $6.85 M   3.26% 2.03%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 3.00 M $6.61 M   6,406.59% 1.96%
D. E. SHAW & CO., INC. 05/15/2025 2.99 M $6.57 M   -19.81% 1.95%
AIGH CAPITAL MANAGEMENT LLC 05/06/2025 2.78 M $6.11 M   100.00% 1.81%
JW ASSET MANAGEMENT, LLC 05/09/2025 2.34 M $5.14 M   1.98% 1.52%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 2.27 M $5.00 M   91.33% 1.48%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 2.24 M $4.92 M   4.45% 1.46%
CONGRESS PARK CAPITAL LLC 04/22/2025 2.04 M $4.48 M   -17.10% 1.33%
MORGAN STANLEY 05/15/2025 1.93 M $4.25 M   -30.81% 1.26%
NEW YORK STATE COMMON RETIREMENT FUND 05/01/2025 1.75 M $3.86 M   32.70% 1.14%
ORCHARD CAPITAL MANAGEMENT, LLC 05/15/2025 1.43 M $3.15 M   -23.70% 0.93%
MILLENNIUM MANAGEMENT LLC 05/15/2025 1.40 M $3.07 M   547.37% 0.91%
MARSHALL WACE, LLP 05/15/2025 1.25 M $2.76 M   23.31% 0.82%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 1.09 M $2.40 M   -1.48% 0.71%
CLEARLINE CAPITAL LP 05/16/2025 1.06 M $2.33 M   -41.46% 0.69%
TWO SIGMA INVESTMENTS, LP 05/15/2025 1.05 M $2.32 M   6.34% 0.69%
GOLDMAN SACHS GROUP INC 06/27/2025 1.03 M $2.26 M   57.01% 0.67%
NORTHERN TRUST CORP 05/13/2025 995.39 K $2.19 M   -1.62% 0.65%
BANK OF AMERICA CORP /DE/ 05/15/2025 968.04 K $2.13 M   -7.52% 0.63%
MONACO ASSET MANAGEMENT SAM 05/08/2025 960.00 K $2.11 M   -20.84% 0.63%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2025 796.10 K $1.75 M   13.73% 0.52%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 700.00 K $1.54 M   133.33% 0.46%
JPMORGAN CHASE & CO 05/12/2025 696.44 K $1.53 M   23.75% 0.45%
TWO SIGMA ADVISERS, LP 05/15/2025 669.17 K $1.47 M   -18.78% 0.44%
CM MANAGEMENT, LLC 05/09/2025 600.00 K $1.32 M   -14.29% 0.39%
RICHMOND BROTHERS, INC. 05/02/2025 544.90 K $1.20 M   -15.17% 0.36%
CITADEL ADVISORS LLC 05/15/2025 501.49 K $1.10 M   100.00% 0.33%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 487.24 K $1.07 M   -0.18% 0.32%
NEXPOINT ASSET MANAGEMENT, L.P. 05/15/2025 475.75 K $1.05 M   0.00% 0.31%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 425.40 K $935.88 K   -78.10% 0.28%
JANE STREET GROUP, LLC 05/19/2025 413.80 K $910.36 K   100.00% 0.27%
TD ASSET MANAGEMENT INC 05/07/2025 394.60 K $868.12 K   100.00% 0.26%
EAM INVESTORS, LLC 05/13/2025 349.00 K $767.80 K   100.00% 0.23%
BANK OF NEW YORK MELLON CORP 04/29/2025 328.34 K $722.35 K   -3.63% 0.21%
JEFFERIES FINANCIAL GROUP INC. 05/08/2025 322.60 K $709.72 K   100.00% 0.21%
05/12/2025 314.28 K $691.41 K   100.00% 0.20%
QUINN OPPORTUNITY PARTNERS LLC 05/14/2025 280.00 K $616.00 K   -26.32% 0.18%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 273.95 K $602.68 K   -1.23% 0.18%
APEIRON RIA LLC 05/29/2025 262.54 K $577.59 K   0.00% 0.17%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2025 229.33 K $504.53 K   417.85% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 199.38 K $438.64 K   241.93% 0.13%

Heron Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 161 institutional investors and hedge funds held shares of Heron Therapeutics, Inc.. The most heavily invested institutionals were:

US BANCORP \DE\: 0

COLDSTREAM CAPITAL MANAGEMENT INC: 0

Quadcap Wealth Management, LLC: 0

XTX Topco Ltd: 0

FRANKLIN RESOURCES INC: 0

EAM Investors, LLC: 0

81.26% of Heron Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 111.15 M shares in the last 24 months. This purchase volume represents approximately $155.61 M in transactions.